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A B S T R A C T
Mammalian sinoatrial node (SAN) cells, the natural pacemaker cells of the heart, 
have an action potential characterized by the presence of a special phase, the slow 
diastolic (pacemaker) depolarization (phase 4), which drives pacemaker activity and 
has therefore attracted the interest of generations of cardiac physiologists. What is the 
basis of the pacemaker depolarization? Here the features of the “funny” (If) current 
of pacemaker cells and its involvement in the generation and autonomic regulation of 
heart rate are briefly addressed. I also address the involvement of If in the pharmaco-
logical control of cardiac chronotropism, and how defective “funny” channels can be 
responsible for inherited heart rhythm disturbances. 
I f  G O V E R N S  T H E  G E N E R A T I O N  A N D  A U T O N O M I C  
C O N T R O L  O F  H E A R T  R A T E
In the original report in the sinoatrial node (SAN) in 1979 (Brown et al., 1979), the 
“funny” If current was described as an inward current activated on hyperpolarization 
in the diastolic range of voltages (Figure 1). Its properties, as well as being relevant 
to the generation of the diastolic depolarization phase of the action potential, were 
shown to be apt to mediate the changes of diastolic depolarization slope, hence of the 
spontaneous rate, caused by ß-receptor stimulation by adrenaline. 
Following its early description, much work was devoted to a thorough investiga-
tion of the properties of If in relation to kinetics, ionic nature and modulation by 
neuromediators (DiFrancesco, 1985; DiFrancesco, 1993). These studies confirmed 
that the pacemaker current is an essential mechanism in the generation of diastolic 
depolarization and thus in the intiation of the heartbeat, but also demonstrated the 
fundamental role of If in mediating the control of cardiac chronotropism by both 
the sympathetic and parasympathetic autonomic inputs (DiFrancesco et al., 1986; 
DiFrancesco et al., 1989).
Which is the mechanism by which If generates spontaneous activity and modulates 
cardiac rate? If is activated by hyperpolarization from a threshold near -40/-50 mV, 
as apparent in Figure 1a,b; its activation curve (i.e., the degree of current activa-
tion at steady-state, Figure 1c) shows that the current activation saturates at about 
-100/-100 mV, demonstrating that the If activation range overlaps that of the diastolic 
depolarization phase of the action potential (Figure 1a). As illustrated by plotting 
the fully-activated I/V relation in Figure 1c, If is inward at diastolic voltages, with a 
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reversal potential near -10/-20 mV, which reflects its mixed 
ionic Na+/K+ permeability (DiFrancesco, 1981a,b). Since the 
activation range of If overlaps that of diastolic depolarization 
(compare panels a and c in Figure 1), the current activates 
during repolarization of the action potential, and since If is 
inward at diastolic voltages, its activation is a suitable mecha-
nism for the generation of the slowly developing pacemaker 
depolarization.
In addition to generating the diastolic depolarization phase 
of the action potential, hence rhythmic activity, If activation is 
the key process in the modulation of rate by autonomic trans-
mitters. The mammalian pacemaker region (SAN) is densely 
innervated by the autonomic nervous system: sympathetic 
ß-adrenergic stimulation accelerates, and parasympathetic 
muscarinic stimulation slows cardiac rate. When isolated 
SAN cells are superfused with solutions containing low con-
centrations of autonomic agonists, changes of spontaneous 
rate are characterized by specific changes of the diastolic 
depolarization rate, without significant modifications of ac-
tion potential duration and shape (Figure 2a). This indicates 
that the process responsible for the diastolic depolarization 
phase of the action potential (i.e. If activation) is the primary 
target of autonomic neurotransmitters. 
Indeed, the original report of If in SAN cells (Brown et al., 
1979) had already identified If as a functionally relevant target 
of adrenergic-induced positive chronotropic effect. Further 
experimentation then showed that ß-adrenergic stimula-
tion increases If by displacing its current activation curve to 
more positive voltages, without modifying its conductance 
(DiFrancesco et al., 1986; Accili et al., 1997; Figure 2b). The 
depolarizing shift of If activation curve caused by ß-adrenergic 
stimulation is due to an increased level of intracellular cAMP, 
which acts as a second messenger in the modulation of funny 
channels (DiFrancesco & Tortora, 1991). This implies that 
ß-receptor stimulation accelerates rate by stimulating adenyl-
ate-cyclase activity and cAMP synthesis, which shifts the If 
activation curve to more positive voltages and thus increases 
the inward current during diastolic depolarization, ultimately 
leading to a faster depolarization rate.
Later studies showed that If is also strongly dependent 
upon parasympathetic stimulation, by a mechanism which is 
opposite to that elicited by â-adrenergic stimulation (DiFran-
FIGURE 1. The “funny” If current. a, spontaneous activity 
recorded from isolated SAN myocytes reveals a slow diastolic 
“pacemaker” depolarization (phase 4 of the action potential) 
from about -60 to -40 mV. b, If current recorded from a SAN 
cell during hyperpolarizing steps from –35 mV to voltages in 
the range –45/–75 mV; the same voltage levels are drawn as 
broken lines in panel a to indicate that the range of If activa-
tion overlaps the diastolic depolarization. c, activation curve 
(left side of y-axis) and I/V relation (right side of the y-axis) of 
If. The activation curve represents the fraction of total current 
activated at each voltage; the I/V relation represents the volt-
age-dependence of the fully-activated current density, normal-
ized to cell capacity. 
FIGURE 2. If mediates the modulation of cardiac rate by the 
autonomic nervous system. a, spontaneous activity recorded 
from a SAN myocyte; activity is accelerated by isoprenaline 
and slowed by acetylcholine, and rate changes do not involve 
changes of action potential shape or duration but are only as-
sociated to changes in the slope of diastolic depolarization. b, 
the If activation curve shifts to the right in the presence of iso-
prenaline and to the left in the presence of acetylcholine, thus 
increasing and decreasing, respectively, the current activated at 
each voltage; these effects are responsible for the changes of 
diastolic depolarization rate shown in panel a. [Modified with 
permission from DiFrancesco, 1993 (a) and Accili et al., 1997 
(b)].
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cesco & Tromba, 1988a). It has been known for a long time 
that vagal stimulation releases acetylcholine (Ach) and slows 
cardiac rate, and based on early experiments (Hutter & Traut-
wein, 1955) it was thought that the mechanism responsible 
for the slowing effect of ACh was an ACh-activated potas-
sium current (Sakmann et al., 1983). This view was however 
challenged by the finding that ACh strongly inhibits If by 
shifting its activation curve to more negative voltages, an ac-
tion opposite to that caused by catecholamines and due to a 
muscarinic-induced inhibition of adenylate-cyclase and cAMP 
reduction (DiFrancesco & Tromba, 1988a, DiFrancesco & 
Tromba, 1988b) (Figure 2a,b). 
How could two different mechanisms, both effective to 
slow cardiac rate upon vagal stimulation, operate simultane-
ously? This puzzle was resolved by investigating the ranges 
of ACh concentration required to induce the two effects. We 
showed that while low doses of ACh (up to 0.01-0.03 µM) are 
able to inhibit If and slow the spontaneous frequency of SAN 
cells, much higher concentrations are required to activate the 
potassium conductance; indeed, the ACh dose required for 
half inhibition of If is some 20-fold lower than the dose half 
activating the K+ current (DiFrancesco et al., 1989). This 
finding introduced a novel concept in cardiac physiology, i.e. 
that the negative chronotropic effect of low-to-moderate vagal 
stimulatory tone is mediated by If inhibition, not by activation 
of a potassium current (DiFrancesco, 1993).
P H A R M A C O L O G I C A L  I N H I B I T I O N  
O F  T H E  F U N N Y  C U R R E N T  
A N D  R A T E - R E D U C I N G  A G E N T S
The discovery of If and the detailed investigation of its 
properties were relevant not only in relation to the understand-
ing of the basic principles underlying pacemaker generation 
and modulation, but also in that it provided the possibility to 
implement an approach to pharmacological control of heart 
rate based on the concept of If and its function. Since both ex-
perimental and mathematical modeling analysis (DiFrancesco 
& Noble, 1985) have clearly established a direct correlation 
between If and pacemaker activity, it is to be expected that If 
inhibition, such as the one that can be achieved by f-channel 
block, can lead to slowing of cardiac rate. 
Several recently developed drugs able to specifically 
slow heart rate without substantial side-effects (the “heart 
rate-inhibiting” substances) have indeed been shown to act 
by selective blockade of f-channels. These agents may have a 
significant impact on specific cardiac therapies, particularly 
when slowing of heart rate is beneficial, such as chronic angina, 
ischemic heart disease and cardiac failure (DiFrancesco & 
Camm, 2004). 
The slowing action of ivabradine (now in the market with 
the commercial name of Procoralan), and the ivabradine-in-
duced inhibition of If, as recorded in single SAN myocytes, 
are shown in Figure 3a,b. 
At the concentration used in Figure 3a (0.3 µM), the bra-
dycardic action of the drug clearly involves a reduced steep-
ness of the diastolic depolarization phase, without substantial 
alterations of either action potential shape or duration. This 
implies that the action of the drug reflects primarily a specific 
inhibition of the funny current. Also, the drug has a “physi-
ological” type of action since it mimics the slowing induced 
by moderate cholinergic activity (compare with Figure 2a), 
although the mode by which ivabradine inhibits f-channels is 
complex and is quite different from a simple leftward shift of 
the activation curve (Bucchi et al, 2002). Block of the f-chan-
nels by ivabradine can be demonstrated by applying repetitive 
activating/deactivating voltage-clamp protocols during expo-
sure to the drug (Figure 3b). The blocking action of ivabradine 
on f-channels has been investigated with some detail (Bois et 
al., 1996; Bucchi et al., 2002). The data show that ivabradine 
inhibits f-channels with a high degree of specificity relative 
to other channels expressed in the SAN and acts as an “open 
f-channel” blocker, implying that the molecule can reach the 
blocking site within the pore only when channels are open 
during hyperpolarization. At the same time, ivabradine blocks 
f-channels preferentially during depolarization, because it is a 
positively charged molecule. The open-channel block, requir-
ing hyperpolarization, and the preferential block on depolar-
ization are contradictory properties. However, this behaviour 
is the basis of the “use-dependent” action of ivabradine, i.e. the 
FIGURE 3. Ivabradine slows pacemaker rate and blocks f-chan-
nels. a, spontaneous activity recorded from a single SAN myo-
cyte is slowed by ivabradine 0.3 µM, through a decreased rate 
of diastolic depolarization. b, ivabradine-induced block of If re-
corded during repetitive activating/deactivating steps (-100/+5 
mV) applied every 6 s from a holding potential of -35 mV.
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requirement of repetitive channel opening/ closing cycles for 
block to develop. This is a useful property because it implies 
that higher degrees of block develop at higher frequencies of 
opening/closing cycles; therefore, the rate-reducing action of 
the drug increases at higher (tachycardic) heart rates, when 
in fact it is more valuable.
Further analysis shows that the blocking action of ivabra-
dine on f-channels differs qualitatively from that of other 
rate-reducing agents such as ZD7288 and zatebradine (UL-
FS49) (DiFrancesco, 1994; Shin et al., 2001). Experimental 
evidence indeed indicates that the ivabradine block of If is 
not simply a voltage-dependent block such as that proposed 
for zatebradine, or a channel state-dependent block as the 
one proposed for ZD 7288. Rather, the ivabradine-induced 
block of If can be shown to depend on the direction of cur-
rent flow, more than on voltage per se (Bucchi et al., 2002). 
A possible interpretation of these features is that ivabradine 
block involves a competition between drug molecules and 
permeating Na+ and/or K+ ions for a common binding site 
within the f-channel pore.
R H Y T H M  D I S T U R B A N C E S  A S S O C I A T E D  
T O  F - C H A N N E L  M O D I F I C A T I O N S
As well as physiologically (by the autonomic transmit-
ters) and pharmacologically (i.e. by the rate-limiting agents), 
f-channel behavior can be altered genetically, by sequence 
mutations. Since HCN channels, the molecular constituents 
of native f-channels, were cloned, several structure-function 
studies have thoroughly demonstrated that the normal func-
tion of channels can be modified by alterations of the channel 
sequence, hence of its structure/gating relation (see Chen et 
al., 2002). This evidence, along with the established notion 
that f-channels are responsible for generation and modulation 
of cardiac rhythm, lead to an obvious question: can naturally 
defective f-channels cause rhythm disturbances? 
This question has been recently answered by the finding 
of a large Italian family where a specific HCN4 mutation 
(S672R) in the cyclic-nucleotide-binding domain (at the C-
terminus) leads to inherited sinus bradycardia (Milanesi et al., 
2006). Of the four known HCN isoforms, HCN4 is the most 
expressed in SAN tissue. In the family investigated, each of the 
bradycardic individuals (rates between 43 and 60 bpm, mean 
of 52.2±1.4 bpm, n=15) carried the same HCN4 mutation, 
while all individuals with normal heart rates (range 64 to 81 
bpm, mean of 73.2±1.6 bpm) had normal HCN4 sequences, 
indicating tight correlation between the HCN4 mutation and 
the bradycardic phenotype. When expressed heterologously 
in HEK293 cells, mutated channels had an activation curve 
which was shifted to more negative voltages relative to wild-
type channels (by about 9 mV). When identical amounts of 
wild-type and mutated channel cDNA’s were transfected in 
order to produce heteromeric channels such as those occurring 
in heterozygotes, the HCN4 activation curve was about 5 mV 
more negative than that of normal channels (Milanesi et al., 
2006). The mutation thus mimicked the action of a low dose 
of ACh (between 10 and 30 nM) (see Fig. 2b), which can fully 
explain the bradycardic phenotype associated to it. 
C O N C L U S I O N
It is well established that the funny current plays an es-
sential role in the generation of the diastolic depolarization 
of cardiac pacemaker cells and in the autonomic modulation 
of heart rate. Recent results show that the relevance of funny 
channels to pacemaker activity applies not only to physi-
ological conditions, but also to pathological conditions, since 
defective channels have been shown to underlie an inherited 
rhythm disturbance such as sinus bradycardia (Milanesi et 
al., 2006). 
Direct control of cardiac chronotropism can be achieved 
by exploiting the features of funny channels. For example, 
pharmacological control of rate can be achieved by the use of 
drugs such as the funny channel inhibitor ivabradine, which 
reduces in a controlled way the amount of If current during 
diastolic depolarization, and hence heart rate, by selective 
f-channel blockade (Bucchi et al., 2002). 
The properties of funny channels can also be exploited 
to the opposite aim, i.e. to enhance the pacemaker func-
tion. Pacemaker activity, for example, can be transferred to 
quiescent cardiac cells by transfecting HCN channels and/or 
delivering stem cells expressing HCN channels (Rosen et al., 
2004). “Biological pacemakers” based on the development 
of the above techniques and exploitation of the properties of 
funny channels may in due time become feasible alternatives 
to electronic pacemakers. 
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